{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:37:42Z","timestamp":1782765462964,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2322026"],"award-info":[{"award-number":["T2322026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Talent Plan of Shanghai Branch, Chinese Academy of Sciences","award":["CASSHB-QNPD-2023-026"],"award-info":[{"award-number":["CASSHB-QNPD-2023-026"]}]},{"name":"International Partnership Program of the Chinese Academy of Sciences","award":["nullGJHZ2024145FN"],"award-info":[{"award-number":["nullGJHZ2024145FN"]}]},{"name":"Yunnan Provincial Xingdian Talent Support Program","award":["XDYC-MY-2022-0059"],"award-info":[{"award-number":["XDYC-MY-2022-0059"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human embryonic stem cells (hESCs), as naturally pluripotent stem cells, constitute a pivotal cell source for cell replacement therapies. Yet, the generation of clinically compliant hESC lines under feeder-free and xeno-free conditions remains inefficient. Moreover, the derivation of hESCs from clinically surplus and discarded low-quality embryos using the standardized, translation-ready culture systems has not been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>By optimizing culture conditions and inner cell mass (ICM) isolation method, we developed a method that significantly improves the derivation efficiency of hESC lines from clinically surplus and discarded frozen-thawed embryos under feeder- and xeno-free conditions. The derivation protocol is operationally simple and easily standardized, with the reagents commercially available and of GMP-grade.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Using this protocol, we successfully established 16 hESC lines. Among blastocysts with morphologically distinct ICMs of grades A and B, the derivation efficiency achieved approximately 60%, with all three grade A ICMs yielding viable hESC lines (100% derivation efficiency for grade A). Notably, for embryos with poorly developed ICMs (grade C), the derivation efficiency of hESC lines approached 30%, showing the protocol\u2019s robustness across varying ICM quality. Adhering to GMP standards, we derived two clinical-grade hESC lines, which were demonstrated biological safety, sustained pluripotency, and the capacity for three-germ-layer differentiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study offers a robust, standardized, and simple method for deriving clinical-grade hESCs. Efficient derivation, propagation and banking of hESC lines from frozen-thawed embryos would offer a valuable cell source for advancing regenerative medicine, disease modeling, and drug development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-025-04831-3","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T08:33:48Z","timestamp":1764578028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A simple and standardized method supports efficient derivation of clinical-grade human embryonic stem cells under feeder- and xeno-free conditions"],"prefix":"10.1186","volume":"17","author":[{"given":"Qiong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huicheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Cun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuansong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"4831_CR1","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1016\/j.cell.2024.09.004","volume":"187","author":"S Wang","year":"2024","unstructured":"Wang S, Du Y, Zhang B, Meng G, Liu Z, Liew SY, Liang R, Zhang Z, Cai X, Wu S, et al. Transplantation of chemically induced pluripotent stem-cell-derived Islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell. 2024;187:6152\u2013e61646118.","journal-title":"Cell"},{"key":"4831_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.stem.2024.12.005","volume":"32","author":"A Kirkeby","year":"2025","unstructured":"Kirkeby A, Main H, Carpenter M. Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update. Cell Stem Cell. 2025;32:10\u201337.","journal-title":"Cell Stem Cell"},{"key":"4831_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145\u20137.","journal-title":"Science"},{"key":"4831_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.molmed.2016.05.010","volume":"22","author":"C Soria-Valles","year":"2016","unstructured":"Soria-Valles C, L\u00f3pez-Ot\u00edn C. iPSCs: on the road to reprogramming aging. Trends Mol Med. 2016;22:713\u201324.","journal-title":"Trends Mol Med"},{"key":"4831_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature09871","volume":"471","author":"SM Hussein","year":"2011","unstructured":"Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, N\u00e4rv\u00e4 E, Ng S, Sourour M, H\u00e4m\u00e4l\u00e4inen R, Olsson C, et al. Copy number variation and selection during reprogramming to pluripotency. Nature. 2011;471:58\u201362.","journal-title":"Nature"},{"key":"4831_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature09805","volume":"471","author":"A Gore","year":"2011","unstructured":"Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature. 2011;471:63\u20137.","journal-title":"Nature"},{"key":"4831_CR7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41588-022-01147-3","volume":"54","author":"FJ Rouhani","year":"2022","unstructured":"Rouhani FJ, Zou X, Danecek P, Badja C, Amarante TD, Koh G, Wu Q, Memari Y, Durbin R, Martincorena I, et al. Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells. Nat Genet. 2022;54:1406\u201316.","journal-title":"Nat Genet"},{"key":"4831_CR8","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1038\/s41467-024-49335-5","volume":"15","author":"R Araki","year":"2024","unstructured":"Araki R, Suga T, Hoki Y, Imadome K, Sunayama M, Kamimura S, Fujita M, Abe M. iPS cell generation-associated point mutations include many C\u2009>\u2009T substitutions via different cytosine modification mechanisms. Nat Commun. 2024;15:4946.","journal-title":"Nat Commun"},{"key":"4831_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.stem.2009.10.009","volume":"5","author":"G Lin","year":"2009","unstructured":"Lin G, Xie Y, Ouyang Q, Qian X, Xie P, Zhou X, Xiong B, Tan Y, Li W, Deng L, et al. HLA-matching potential of an established human embryonic stem cell bank in China. Cell Stem Cell. 2009;5:461\u20135.","journal-title":"Cell Stem Cell"},{"key":"4831_CR10","doi-asserted-by":"publisher","first-page":"e35325","DOI":"10.1371\/journal.pone.0035325","volume":"7","author":"SE Tannenbaum","year":"2012","unstructured":"Tannenbaum SE, Turetsky TT, Singer O, Aizenman E, Kirshberg S, Ilouz N, Gil Y, Berman-Zaken Y, Perlman TS, Geva N, et al. Derivation of xeno-free and GMP-grade human embryonic stem cells\u2013platforms for future clinical applications. PLoS ONE. 2012;7:e35325.","journal-title":"PLoS ONE"},{"key":"4831_CR11","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/nprot.2012.080","volume":"7","author":"E Stephenson","year":"2012","unstructured":"Stephenson E, Jacquet L, Miere C, Wood V, Kadeva N, Cornwell G, Codognotto S, Dajani Y, Braude P, Ilic D. Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment. Nat Protoc. 2012;7:1366\u201381.","journal-title":"Nat Protoc"},{"key":"4831_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.stemcr.2017.04.017","volume":"9","author":"Q Gu","year":"2017","unstructured":"Gu Q, Wang J, Wang L, Liu ZX, Zhu WW, Tan YQ, Han WF, Wu J, Feng CJ, Fang JH, et al. Accreditation of biosafe Clinical-Grade human embryonic stem cells according to Chinese regulations. Stem Cell Rep. 2017;9:366\u201380.","journal-title":"Stem Cell Rep"},{"key":"4831_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13287-018-0866-5","volume":"9","author":"C Laowtammathron","year":"2018","unstructured":"Laowtammathron C, Chingsuwanrote P, Choavaratana R, Phornwilardsiri S, Sitthirit K, Kaewjunun C, Makemaharn O, Terbto P, Waeteekul S, Lorthongpanich C, et al. High-efficiency derivation of human embryonic stem cell lines using a culture system with minimized trophoblast cell proliferation. Stem Cell Res Ther. 2018;9:138.","journal-title":"Stem Cell Res Ther"},{"key":"4831_CR14","doi-asserted-by":"publisher","first-page":"15062","DOI":"10.1038\/s41598-023-42236-5","volume":"13","author":"T Souralova","year":"2023","unstructured":"Souralova T, Hulinova D, Jeseta M, Ventruba P, Hampl A, Koutna I. Truncated vitronectin with E-cadherin enables the xeno-free derivation of human embryonic stem cells. Sci Rep. 2023;13:15062.","journal-title":"Sci Rep"},{"key":"4831_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.reth.2022.10.006","volume":"21","author":"K Takada","year":"2022","unstructured":"Takada K, Nakatani R, Moribe E, Yamazaki-Fujigaki S, Fujii M, Furuta M, Suemori H, Kawase E. Efficient derivation and banking of clinical-grade human embryonic stem cell lines in accordance with Japanese regulations. Regen Ther. 2022;21:553\u20139.","journal-title":"Regen Ther"},{"key":"4831_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41591-021-01645-7","volume":"28","author":"Y Du","year":"2022","unstructured":"Du Y, Liang Z, Wang S, Sun D, Wang X, Liew SY, Lu S, Wu S, Jiang Y, Wang Y, et al. Human pluripotent stem-cell-derived Islets ameliorate diabetes in non-human primates. Nat Med. 2022;28:272\u201382.","journal-title":"Nat Med"},{"key":"4831_CR17","doi-asserted-by":"publisher","first-page":"e715","DOI":"10.1002\/ctm2.715","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang H, Xu L, Han S, Wang X, Wang H, Zhou J, Shen J, Yang Z, Yu L, Huang Z, et al. Hyperactivation of platelet-derived growth factor signalling contributes to arrhythmogenesis in Brugada syndrome. Clin Transl Med. 2022;12:e715.","journal-title":"Clin Transl Med"},{"key":"4831_CR18","doi-asserted-by":"crossref","unstructured":"Li Z, Duan H, Jia Y, Zhao C, Li W, Wang X, Gong Y, Dong C, Ma B, Dou S et al. Long-term corneal recovery by simultaneous delivery of hPSC-derived corneal endothelial precursors and nicotinamide. J Clin Invest 2022, 132.","DOI":"10.1172\/JCI146658"},{"key":"4831_CR19","doi-asserted-by":"publisher","first-page":"7156","DOI":"10.2741\/3218","volume":"13","author":"J Suckale","year":"2008","unstructured":"Suckale J, Solimena M. Pancreas Islets in metabolic signaling\u2013focus on the beta-cell. Front Biosci. 2008;13:7156\u201371.","journal-title":"Front Biosci"},{"key":"4831_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.fertnstert.2018.03.032","volume":"110","author":"M Irani","year":"2018","unstructured":"Irani M, O\u2019Neill C, Palermo GD, Xu K, Zhang C, Qin X, Zhan Q, Clarke RN, Ye Z, Zaninovic N, Rosenwaks Z. Blastocyst development rate influences implantation and live birth rates of similarly graded euploid blastocysts. Fertil Steril. 2018;110:95\u2013e102101.","journal-title":"Fertil Steril"},{"key":"4831_CR21","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/humrep\/dez129","volume":"34","author":"C Hernandez-Nieto","year":"2019","unstructured":"Hernandez-Nieto C, Lee JA, Slifkin R, Sandler B, Copperman AB, Flisser E. What is the reproductive potential of day 7 euploid embryos? Hum Reprod. 2019;34:1697\u2013706.","journal-title":"Hum Reprod"},{"key":"4831_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/cr.2007.61","volume":"17","author":"T Lei","year":"2007","unstructured":"Lei T, Jacob S, Ajil-Zaraa I, Dubuisson JB, Irion O, Jaconi M, Feki A. Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges. Cell Res. 2007;17:682\u20138.","journal-title":"Cell Res"},{"key":"4831_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13287-017-0561-y","volume":"8","author":"J Ye","year":"2017","unstructured":"Ye J, Bates N, Soteriou D, Grady L, Edmond C, Ross A, Kerby A, Lewis PA, Adeniyi T, Wright R, et al. High quality clinical grade human embryonic stem cell lines derived from fresh discarded embryos. Stem Cell Res Ther. 2017;8:128.","journal-title":"Stem Cell Res Ther"},{"key":"4831_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nbt1310","volume":"25","author":"K Watanabe","year":"2007","unstructured":"Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T, Takahashi JB, Nishikawa S, Nishikawa S, Muguruma K, Sasai Y. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol. 2007;25:681\u20136.","journal-title":"Nat Biotechnol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04831-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:05:25Z","timestamp":1767679525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04831-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4831"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04831-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All work with human embryos and hESC derivation was approved by the Medical Ethics Committee of Affiliated Hospital of Yunnan University. Title of the approved project: Establishment of human embryonic stem cell lines using clinically surplus and discarded blastocysts generated by in vitro fertilization. Approval number: 2023224. Date of approval: September 7, 2023. Informed consent was obtained from all couples who donated their embryos for the present study. All animal experiments were approved by the Animal Ethics Committee of Hangzhou Institute of Medicine, Chinese Academy of Sciences and conducted in accordance with the guidelines. Title of the approved project: In vivo evaluation of tumorigenic capacity of different pluripotent stem cell states. Approval number: AP2024-10-0307. Date of approval: October 31, 2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors confirm their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}